Seascape Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Seascape Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,178	Closed	-$203K	–	97
2023 Q2	$203K	Sell	3,178 -90	-3%	-$6.04K	0.1%	95
2023 Q1	$227K	Buy	3,268 +69	+2%	+$4.87K	0.12%	91
2022 Q4	$230K	Sell	3,199 -744	-19%	-$56.1K	0.13%	93
2022 Q3	$280K	Buy	3,943 +805	+26%	+$58.4K	0.19%	77
2022 Q2	$242K	Buy	+3,138	New	+$239K	0.15%	79

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Seascape Capital Management's BMY Position: Q3 2023 in Review

Seascape Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,178 shares — an estimated $203K sold.

Seascape Capital Management first reported a position in BMY in Q2 2022 and held it in 5 quarters. The position peaked at $280K in Q3 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Seascape Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Seascape Capital Management sold 3,178 Bristol-Myers Squibb shares in Q3 2023, an estimated $203K.
Seascape Capital Management first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 5 quarters.
Seascape Capital Management's Bristol-Myers Squibb position peaked at $280K in Q3 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Seascape Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.